A detailed history of Johnson Financial Group, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 945 shares of UTHR stock, worth $352,381. This represents 0.02% of its overall portfolio holdings.

Number of Shares
945
Previous 1,306 27.64%
Holding current value
$352,381
Previous $416,000 18.75%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$311.04 - $363.55 $112,285 - $131,241
-361 Reduced 27.64%
945 $338,000
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $298,107 - $416,666
1,306 New
1,306 $416,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Johnson Financial Group, Inc. Portfolio

Follow Johnson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.